{"@context":"https://schema.org","@type":"Corporation","name":"JAGSONPAL PHARMACEUTICALS","alternateName":"JAGSNPHARM","tickerSymbol":"JAGSNPHARM","identifier":"JAGSNPHARM","description":"JAGSONPAL PHARMACEUTICALS (JAGSNPHARM) financials: Market Cap ₹1,440Cr., Price ₹218, P/E 30.6, ROE 17.3%. Jun 2026: sales ₹82 Cr, net profit ₹13 Cr. Quarterly…","url":"https://fincrux.org/companies/JAGSNPHARM","sameAs":["https://fincrux.org/companies/JAGSNPHARM"],"dateModified":"2026-10-18T18:00:14.572947","additionalProperty":[{"@type":"PropertyValue","name":"Market Cap","value":"₹1,440Cr."},{"@type":"PropertyValue","name":"Current Price","value":"₹218"},{"@type":"PropertyValue","name":"Stock P/E","value":"30.6"},{"@type":"PropertyValue","name":"ROE","value":"17.3%"},{"@type":"PropertyValue","name":"ROCE","value":"22.7%"},{"@type":"PropertyValue","name":"Book Value","value":"₹41.2"},{"@type":"PropertyValue","name":"Dividend Yield","value":"1.83%"},{"@type":"PropertyValue","name":"52W High / Low","value":"₹265/155"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://fincrux.org/companies/JAGSNPHARM#webpage","name":"JAGSONPAL PHARMACEUTICALS (JAGSNPHARM) Financials, Quarterly Results & Ratios","url":"https://fincrux.org/companies/JAGSNPHARM","isPartOf":{"@id":"https://fincrux.org/#website"}},"publisher":{"@type":"Organization","name":"Fincrux","url":"https://fincrux.org"},"potentialAction":{"@type":"ViewAction","target":"https://fincrux.org/companies/JAGSNPHARM"}}